InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: couldbebetter post# 324513

Wednesday, 02/10/2021 8:28:32 AM

Wednesday, February 10, 2021 8:28:32 AM

Post# of 425933
c-

Not really! AMRN must proceed in a GIA fashion even if a BO were in active discussions

It is true ... every company has to operate as GIA till Bo'd. The difference is the "level / fashion"

because AMRN must demonstrate that they are capable of GIA even if the company were not sold.

Nope. Amarin does not have to demonstrate anything ... it is not a pissing contest or WWE. Amarin is running as a GIA for a long time, nobody has any doubt about they could run as a GIA forever.

if a BO were in active discussions

I take "active" as real, strong interest when the outcome is more likely positive in the near future ... In this case nobody start a new, long term project (new Co. in Switzerland), hire new (additional!) employees ... throw money out of the window.

Simple logic is that Vascepa's approval in Europe is worth much more in the hands of an established BP there that has a massive sales force than it ever would be in the "capable" hands of John Thero!

Maybe yes, maybe no ... but it is not a real question, the question is: Do the BP(s) value the Co for more than it worth as a GIA?

BP should understand exactly what Vascepa would be worth in their own hands.

I am sure BP(s) understand more exactly than you or me ... or anybody on this board ... the value of Vascepa, but it looks like it is definitely lower than most of yours since no BO YTD.

To avoid any doubt: GIA (Amarin) valuation is not a number by JT or the BoD out from the thin air, but a very detailed (realistic) calculation by the Co itself (and/) or by an external Co. (let say it is X)

If the offer (Y) - if any - is bigger than X the Co will be sold ... If not, will not be ...

Nobody - including me - ruled out a BO, however the communication, activity, etc. by Amarin suggest that the BO is not imminent (2-3 months) ... Again: it is about the numbers and is not about egos.

China is being set up for potentially making some BP a great deal of money if they can provide enough product for Eddingpharm. However, Europe is still the "Big Kahuna" money maker...in the right hands!

Looks like (currently) BPs think differently ... you are wrong or they are wrong ...

Best,
G

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News